T. Rowe Price Associates’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $188K | Sell |
|
|||||
|
2022
Q1 | $162K | Buy |
|
|||||
|
2021
Q4 | $143K | Sell |
|
|||||
|
2021
Q3 | $482K | Sell |
|
|||||
|
2021
Q2 | $2.11M | Sell |
|
|||||
|
2021
Q1 | $8.19M | Sell |
|
|||||
|
2020
Q4 | $16.8M | Sell |
|
|||||
|
2020
Q3 | $18.9M | Sell |
|
|||||
|
2020
Q2 | $32.6M | Buy |
|
|||||
|
2020
Q1 | $21.4M | Sell |
|
|||||
|
2019
Q4 | $34.5M | Buy |
|
|||||
|
2019
Q3 | $320K | Sell |
|
|||||
|
2019
Q2 | $7.98M | Buy |
|
|||||
|
2019
Q1 | $5.01M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $4.51M | Buy |
|
|||||
|
2017
Q3 | $280K | Hold |
|
|||||
|
2017
Q2 | $222K | Sell |
|
|||||
|
2017
Q1 | $271K | Buy |
|
|||||
|
2016
Q4 | $191K | Sell |
|
|||||
|
2016
Q3 | $265K | Buy |
|
|||||
|
2016
Q2 | $199K | Buy |
|
|||||
|
2016
Q1 | $150K | Hold |
|
|||||
|
2015
Q4 | $199K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $15.9M | Buy |
|
|||||
|
2014
Q2 | $16.3M | Buy |
|